Biosafety Features of Lentiviral Vectors
- 10 January 2013
- journal article
- review article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 24 (2) , 132-142
Abstract
Over the past decades, lentiviral vectors have evolved as a benchmark tool for stable gene transfer into cells with a high replicative potential. Their relatively flexible genome and ability to transduce many forms of nondividing cells, combined with the potential for cell-specific pseudotyping, provides a rich resource for numerous applications in experimental platforms and therapeutic settings. Here, we give an overview of important biosafety features of lentiviral vectors, with detailed discussion of (i) the principles of the lentiviral split-genome design used for the construction of packaging cells; (ii) the relevance of modifications introduced into the lentiviral long terminal repeat (deletion of enhancer/promoter sequences and introduction of insulators); (iii) the basic features of mRNA processing, including the Rev/Rev-responsive element (RRE) interaction and the modifications of the 3′ untranslated region of lentiviral vectors with various post-transcriptional regulatory elements affecting transcriptional termination, polyadenylation, and differentiation-specific degradation of mRNA; and (iv) the characteristic integration pattern with the associated risk of transcriptional interference with cellular genes. We conclude with considerations regarding the importance of cell targeting via envelope modifications. Along this course, we address canonical biosafety issues encountered with any type of viral vector: the risks of shedding, mobilization, germline transmission, immunogenicity, and insertional mutagenesis.Keywords
This publication has 114 references indexed in Scilit:
- Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich SyndromeMolecular Therapy, 2013
- Lentiviral Vector Induced Insertional Haploinsufficiency of Ebf1 Causes Murine LeukemiaMolecular Therapy, 2012
- Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low GenotoxicityMolecular Therapy, 2012
- Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular ReprogrammingMolecular Therapy, 2011
- Solving the Problem of γ-Retroviral Vectors Containing Long Terminal RepeatsMolecular Therapy, 2011
- Correction of β‐thalassemia major by gene transfer in haematopoietic progenitors of pediatric patientsEMBO Molecular Medicine, 2010
- Entry kinetics and cell–cell transmission of surface‐bound retroviral vector particlesThe Journal of Gene Medicine, 2010
- LEDGF Hybrids Efficiently Retarget Lentiviral Integration Into HeterochromatinMolecular Therapy, 2010
- Genomic and Functional Assays Demonstrate Reduced Gammaretroviral Vector Genotoxicity Associated With Use of the cHS4 Chromatin InsulatorMolecular Therapy, 2009
- Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus VectorsMolecular Therapy, 2008